B.3 PriceCost Schedule_updated.xlsx
XLSX spreadsheet 12 KB Posted
- Attached to
- 6505--VA Loma Linda Radiopharmaceuticals
- Solicitation number
- 36C26224Q1356
About this file
This document is a combined synopsis/solicitation for an Indefinite-Delivery Indefinite-Quantity (IDIQ) contract for radiopharmaceuticals to be provided to the Department of Veterans Affairs Loma Linda Healthcare System. The solicitation requests quotes for a base year plus four option years, with estimated quantities provided for each radiopharmaceutical product. The contract will be awarded as a firm-fixed-price contract under FAR Part 12 for commercial items. Key details include:
The contract will be for the following radiopharmaceuticals with estimated quantities per year: 18-FDG, F18 NAF, F-18 FDG, Sodium Iodide I-123 and I-131, In-111 Pentetreotide, Tc-99m radiopharmaceuticals, and other ancillary items. The contract has a minimum order of $30,000 and a maximum of $5,000,000. Quotes are due by July 22, 2024, and the contract term is from October 1, 2024 through September 30, 2029. The North American Industry Classification System (NAICS) code is 325412 with a size standard of 1,300 employees. All offerors must be registered in SAM.gov.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C26224Q1356 0002.docx | DOCX document | |
| 36C26224Q1356 0001.docx | DOCX document | |
| B.3 PriceCost Schedule.xlsx | XLSX spreadsheet | |
| 36C26224Q1356.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| Requesting Radiopharmaceuticals | Estimated Quantities | Base Year Pricing | Base Estimated Total Cost | OY1 Pricing | OY1 Estimated Total Cost | OY2 Pricing | OY2 Estimated Total Cost | OY3 Pricing | OY3 Estimated Total Cost | OY4 Pricing | OY4 Estimated Total Cost |
| 18-FDG 12 mCi per dose | 240 | ||||||||||
| F18 NAF 10 mCi | 240 | ||||||||||
| F-18 FDG US (30mCi max)- Linearity- Source | 4 | ||||||||||
| F-18 FDG Dispensing Fee (if applicable) | 240 | ||||||||||
| Sodium Iodine I-123 200 uci per dose | 35 | ||||||||||
| Sodium Iodide I-131 First 6 mCi (Diagnostic) | 10 | ||||||||||
| Sodium Iodide I-131 Therapy Caps each additional mCi | 30 | ||||||||||
| In-111 Pentetreotide UD | 25 | ||||||||||
| Sincalide Vile | 80 | ||||||||||
| Tc-99m non- HEU Examatazime UD | 5 | ||||||||||
| Tc-99m Non-HEU Filtered Sulfer Colloid U | 20 | ||||||||||
| Tc-99m Non =-HEU Macro Aggregated Albumin | 100 | ||||||||||
| Tc-99m Non- HEU Mebrofenin UD | 150 | ||||||||||
| Tc-99m Non_HEU Medronate UD | 600 | ||||||||||
| Tc-99m Non -HEU Mertiatide UD | 65 | ||||||||||
| Tc-99m Non-HEU NaTc04 MD | 30 | ||||||||||
| Tc-99m Non-HEU NaTc04 UD mCi | 25 | ||||||||||
| Tc-99m Non-HEU Pentetate UD | 100 | ||||||||||
| Tc-99m Non-HEU Pyrophosphate UD | 60 | ||||||||||
| Tc-99m Non-HEU Sestamnib UD | 60 | ||||||||||
| Tc-99m Non-HEU Sulfer Colloid UD | 135 | ||||||||||
| Tc-99m Non-HEU Tetrofsmin UD | 2,500 | ||||||||||
| Tc-99m Non- HEU Autologous WBC Suspension | 40 | ||||||||||
| Nephroscan | 10 | ||||||||||
| Tc-99m Non HEU Mertiatide | 50 | ||||||||||
| Stat | 300 | ||||||||||
| Balloons for H Pylori breath test (sets) | 4 | ||||||||||
| Halyard PY Test Breath Collection fluid | 4 | ||||||||||
| Liquid Scintillation (sets) | 4 | ||||||||||
| C-14 Urea Capsule | 150 | ||||||||||
| F-18 Sodium Flouride | 10 | ||||||||||
| Gallium 67 5 mci | 4 | ||||||||||
| Estimated Total | $ - 0 | $ - 0 | $ - 0 | $ - 0 | $ - 0 | ||||||
| Esetimated Total Cost of the IDIQ contract | $ - 0 |
File details come from the government source that posted it. Updated .